A structured approach to patient onboarding that predicts long-term retention and protocol success, with specific checkpoints and communication cadences.
Why the First 90 Days Determine Everything Patient retention in longevity medicine is determined almost entirely by what happens in the first 90 days. A patient who completes a full 90-day cycle—baseline labs, protocol initiation, early check-in, mid-protocol assessment, 12-week labs, progress review—has dramatically higher lifetime value than one who drops out at day 45. The first 90 days are the patient's "proof of concept" window. They entered the clinic with expectations about what peptide therapy would deliver. Your job is to systematically show them it's delivering.
### Phase 1: Baseline and Education (Days 1–14)
The patient arrives with labs already completed (via pre-visit ordering). The first visit focuses on three outcomes: education, protocol selection, and expectation-setting.
During the visit:
Communication: Patient receives a summary email same day, with appointment notes, protocol details, and links to educational resources.
Measurement: Document baseline, confirm understanding via signed informed consent, verify protocol was initiated.
### Phase 2: Tolerance and Adherence (Days 15–42)
This is the critical window where side effects emerge, compliance questions arise, and abandonment risk is highest.
Week 2 check-in: A nurse or clinical coordinator calls or emails: "How are you tolerating the protocol? Any questions on injection technique or timing?" Document any side effects and provide guidance. Most patients at this stage are fine but appreciate the touchpoint.
Week 4 check-in: Brief assessment. "How's your energy? Sleep? Any changes?" This is where early responders confirm subjective improvements, or where side effects escalate. If a patient reports significant side effects, escalate to the physician for dose adjustment or protocol modification.
Communication: Check-in cadence should be automated reminders, not dependent on staff memory. A system flagging "patient initiated Jan 15, week 2 touchpoint due Jan 29" is critical.
Measurement: Adherence verification (injections completed on schedule), side effect inventory, early subjective improvements documented.
### Phase 3: Protocol Assessment (Days 43–84)
By week 6, protocol tolerance is clear and early subjective changes should be evident.
Week 6 full review: In-person or telehealth visit with physician. Discuss: How are you feeling? Any side effects? Changes in sleep, energy, recovery? Protocol continues as-is, modified, or discontinued based on response.
At week 6, labs are not yet valuable (most biomarkers require 8–12 weeks to shift meaningfully), but the *discussion* about what you'll measure at week 12 is. "At your 12-week labs, we'll check your IGF-1, metabolic markers, and inflammatory status to quantify what you're experiencing subjectively."
This forward-looking communication creates expectation and engagement.
Communication: Physician notes documenting visit. Progress summary to patient. Reminder about 12-week lab ordering.
Measurement: Subjective tolerability confirmed, protocol adherence assessed, early biomarker expectations set.
### Phase 4: Data-Driven Reaffirmation (Days 85–90)
The 12-week labs are the pivot point. This is where subjective benefit becomes objective proof.
Week 12 labs and review: Labs are ordered at week 11, results reviewed by physician at week 12, and patient notified with visualization.
The notification should be specific: "Your IGF-1 increased from 110 to 148. Your inflammatory marker (hsCRP) dropped from 2.8 to 1.8. Your metabolic panel shows improved insulin sensitivity. The protocol is working."
If labs show minimal improvement, the conversation shifts: "Results are in line with expectations for this timepoint. We can continue, adjust dosing, or add a complementary protocol. Let's discuss."
If labs show concerning changes, escalate: "Your kidney function markers shifted. Let's review your hydration, dose, and determine if we need adjustment."
Communication: Detailed lab review letter. Patient dashboard updated with results and trends. Scheduled 90-day summary call.
90-day summary call: This is the capstone. Physician reviews the full 90 days: "You started with clear goals. Here's what we've accomplished in 12 weeks. Here's the trajectory we expect over the next 6 months. Here's what success looks like at month 6."
Measurement: Quantified biomarker changes, protocol continuation vs. modification documented, next 90-day plan established.
Systematize communication so nothing is missed:
|---|---|---|---|---|
At day 91, the patient shouldn't return to silence. Instead, transition to the long-term engagement cadence:
The 90-day onboarding sets the operational template for the entire patient relationship. If you've systematized it well, replicating it across dozens of patients becomes operationally efficient, not a burden.
This framework only works if it's systematized. Use practice management or protocol tracking software that:
A clinic with 200 active patients cannot manage 90-day onboarding through spreadsheets and memory. Automation is mandatory.
Clinics that implement this framework report 70–80% patient retention at month 4, compared to 50–60% for clinics with ad-hoc onboarding. That difference—10–30 additional retained patients per 100 initiated—represents substantial revenue and allows predictable practice growth.
Moreover, structured onboarding generates longitudinal data. You know exactly which protocols, dosing strategies, and patient profiles lead to strong outcomes. This intelligence feeds back into protocol refinement, making every cohort stronger than the last.
---
Disclaimer: This article is for informational and educational purposes only. It does not constitute medical, legal, or financial advice. Clinic operators should consult qualified legal counsel, compliance advisors, and medical boards for guidance specific to their practice and jurisdiction. MyProtocolStack is a protocol tracking and blood work analysis platform — it is not a medical device and does not provide clinical recommendations.
Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers -- not generic charts.
Start Free →